- Amended Statement of Beneficial Ownership (3/A)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Goldsmith Bruce A

2. Date of Event Requiring Statement (MM/DD/YYYY) 8/27/2010

3. Issuer Name and Ticker or Trading Symbol

ALLOS THERAPEUTICS INC [ALTH]

(Last) (First) (Middle)

11080 CIRCLEPOINT ROAD, SUITE 200

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
VP, Corporate Development /

(Street)

WESTMINSTER, CO 80020

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

9/3/2010

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	26812 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	9/10/2009 ⁽²⁾	9/10/2018	Common Stock	100000	$7.90	D
Employee Stock Option (Right to Buy)	2/23/2010 ⁽²⁾	2/23/2019	Common Stock	15000	$6.40	D
Employee Stock Option (Right to Buy)	2/22/2011 ⁽²⁾	2/22/2020	Common Stock	40500	$7.56	D

Explanation of Responses:
( 1)	Represents shares of common stock issued as restricted stock units ("RSUs") awarded under the Company's 2008 Equity Incentive Plan (the "Plan"), excluding 1,250 shares which previously vested and were sold prior to the Reporting Person becoming subject to Section 16 reporting requirements. The RSUs vest in a series of four (4) successive equal annual installments over the four (4)-year period measured from the Vesting Commencement Date. The vested RSU shares have been or will be delivered to the Reporting Person on each such annual anniversary of the Vesting Commencement Date, provided that at the relevant vesting dates the Reporting Person's continuous service to the Company has not been terminated as defined in or as determined under the Plan.
( 2)	Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the vesting commencement date and an additional one-forty-eigths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.

Remarks:
All information on this report was previously filed on 9/3/2010. This amendment is being filed solely to add the Power of Attorney as an exhibit.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Goldsmith Bruce A 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER, CO 80020			VP, Corporate Development

Signatures
/s/ David C. Clark, Attorney-in-Fact for Bruce A. Goldsmith		9/15/2010
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.